PA
TMCI icon

Parallel Advisors’s Treace Medical Concepts TMCI Stock Holding History

Parallel Advisors’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-148
Closed -$1.24K – 3694
2025
Q1 		$1.24K Buy
+148
New +$1.33K ﹤0.01% 3077
2024
Q3 		– Sell
-145
Closed -$964 – 3472
2024
Q2 		$964 Buy
145
+136
+1,511% +$1.1K ﹤0.01% 2969
2024
Q1 		$117 Hold
9
– – ﹤0.01% 3201
2023
Q4 		$115 Buy
+9
New +$91 ﹤0.01% 3219

Other funds holding TMCI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Parallel Advisors's TMCI Position: Q2 2025 in Review

Parallel Advisors sold out of Treace Medical Concepts (TMCI) in Q2 2025, closing a stake of 148 shares — an estimated $1.24K sold.

Parallel Advisors first reported a position in TMCI in Q4 2023 and held it in 4 quarters. The position peaked at $1.24K in Q1 2025. 125 funds tracked by Wall St. Rank hold TMCI as of Q2 2025.

  • Parallel Advisors reported no remaining Treace Medical Concepts position as of Q2 2025 after selling out during the quarter.
  • Parallel Advisors sold 148 Treace Medical Concepts shares in Q2 2025, an estimated $1.24K.
  • Parallel Advisors first reported a position in Treace Medical Concepts in Q4 2023 and held it in 4 quarters.
  • Parallel Advisors's Treace Medical Concepts position peaked at $1.24K in Q1 2025.
  • 125 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2025.

Based on Parallel Advisors's 13F filing for Q2 2025, filed 8 Jul 2025.